Bacterial microcompartments (BMCs) are selectively permeable proteinaceous organelles which encapsulate segments of metabolic pathways across bacterial phyla. They consist of an enzymatic core surrounded by a protein shell composed of multiple distinct proteins. Despite great potential in varied biotechnological applications, engineering efforts have been stymied by difficulties in their isolation and characterization and a dearth of robust methods for programming cores and shell permeability. We address these challenges by functionalizing shell proteins with affinity handles, enabling facile complementation-based affinity purification (CAP) and specific cargo docking sites for efficient encapsulation via covalent-linkage (EnCo). These shell functionalizations extend our knowledge of BMC architectural principles and enable the development of minimal shell systems of precisely defined structure and composition. The generalizability of CAP and EnCo will enable their application to functionally diverse microcompartment systems to facilitate both characterization of natural functions and the development of bespoke shells for selectively compartmentalizing proteins.
Bacterial microcompartments (BMCs) are ensembles of enzymes enclosed in a semi-permeable proteinaceous shell, compositionally distinguishing them from the more familiar lipid-membrane bound organelles of eukaryotes. These compartments have been bioinformatically identified in the majority of bacterial phyla1 where they perform distinct, spatially separate metabolic functions allowing their hosts to fix carbon, as in the anabolic carboxysomes, or metabolize substrates like ethanolamine that generate volatile or toxic intermediates, as in the catabolic metabolosomes.
The shells of all characterized BMCs include a suite of cyclically symmetric protein building blocks which are hexagonal or pentagonal in shape and which together assemble into icosahedral bodies2,3. The hexagons are hexa- or trimeric oligomers of a conserved, single or tandem-duplicated protein domain (pfam00936) that constitute the facets of the shell. Pentamers formed by the pfam03319 domain occupy the vertices. Pores in the hexamer and trimer (BMC-H and BMC-T) subunits mediate passage of small molecules through the shells4,5. In all characterized BMCs, the presence of multiple BMC-H and/or BMC-T homologs, each with distinct pore-lining residues, indicate differences in selectivity of transport among these subunits. In contrast to their roles in molecular selectivity, the structural necessity of multiple homologs remains underexplored. Pentamers are a minor component of shells as they occupy only the 12 vertex positions and are not thought to play a role in transport, yet are critical to the shell’s function as a diffusive barrier6. The enzyme core of BMCs is assembled into the interior of shells through non-covalent interactions between short encapsulation peptides (EPs) on the cargo and the lumenal side of shell proteins7,8,9. A second mode of encapsulation involves piggybacking of EP-less enzymes via interactions with EP-harboring proteins10.
The genetic organization of BMC core and shell proteins into superloci1 and evidence of horizontal transfer among bacterial species11,12 denote BMCs as genetically encoded metabolic modules. Genetic transplantation of such loci has been shown to confer novel metabolic functions to the recipient allowing, for example, Escherichia coli to grow on 1,2-propanediol after transfer of the pdu operon from Citrobacter freundii13. Indeed, repurposing BMCs to encapsulate non-native pathways could allow metabolic engineers to improve titers by increasing enzyme stability, improving flux by concentrating intermediates and mitigating diversion of substrates to competing pathways, and sequestering potentially toxic or inhibitory intermediates14,15,16. Moreover, the nanoscale dimensions and greatly improved understanding of structure and assembly principles described recently2 suggest BMC shells are scaffolds fit for refactoring towards biomedical applications like polyvalent antigen display, drug delivery, and imaging—applications that have traditionally been the purview of other nanocompartments such as virus-like particles and ferritins17,18.
Hampering these ambitions are several technical challenges. Preparations of BMCs or BMC shells are laborious and typically result in low yields of heterogeneous particles (with some notable exceptions19,20). Targeting heterologous cargo to the lumen of shells using EPs that are derived from naturally occurring BMCs is inefficient, with western blotting often required to identify cargo in shell preparations19,20,21,22. EPs may also lead to aggregation, potentially compromising enzyme activity23, and the binding site of EPs is unknown so cargo loading in shells is not readily programmable. Furthermore, there is no disassembly/reassembly methods developed which would allow in vitro encapsulation of cargo.
Here, through rational modifications to shell proteins in our model BMC system HO (from Haliangium ochraceum), we report the development of the CAP and EnCo methods. Complementation-based Affinity Purification (CAP) enables facile screening of assembly and rapid purification of shells. We apply this method to demonstrate a remarkable plasticity of subunit composition in HO shells. Encapsulation via Covalent-linkage (EnCo) is used to robustly program multiple cargo species into shells at predictable ratios both in vivo and ex vivo, enabling the encapsulation of heterologously produced cargo and abiotic materials. Finally, we apply a fluorescence-based probe to assess the permeability of our engineered shells and find they maintain their barrier functionality against macromolecular species while permitting ingress of a small molecule—likely through the pores of one or more shell proteins. These methodological advances should be applicable to other BMC systems, simplifying and accelerating assembly and permeability studies as well as elevate BMC shells to the pantheon of well-characterized and engineerable nanoparticles, enabling their application towards metabolic engineering and biomedical applications.
Shells lacking pentamers can be capped and affinity purified
To obtain a crystal structure of synthetic BMC shells it was necessary to supplement shells with additional copies of the pentamer-forming proteins. This suggests substoichiometric production of pentamer during expression of the Haliangium ochraceum (HO) shell synthetic operon2. Previously, we had observed that facets assembled into three-dimensional particles independent of the presence of pentamers20; taken together, these findings suggested a strategy for producing shells lacking vertices that could be subsequently capped and purified. We hypothesized that appending a high affinity, specific tag such as the Strep-II sequence24 to the pentamer (PSII) would enable pull-downs of shells after capping. Additionally, affixing the ten residues, 1.2 kDa Strep-II tag to the pentamer would result in a size shift allowing it to be resolved from the 10.1 kDa hexamer protein via SDS-PAGE analysis. These combined properties would enable rapid purification and analysis of shells by obviating the need for laborious and technically demanding density gradient ultracentrifugation and ion-exchange chromatography steps.
We validated this hypothesis by comparing classically2,20 prepared HO shells comprised of a single hexamer and three trimer homologs (HT1T2T3 shells; uncapped shells were used because the co-migrating pentamer and hexamer bands preclude fair comparison between samples) to capped HT1T2T3PSII shells prepared by two methods. In the first method, which recapitulates normal in vivo assembly of shells, PSII proteins were co-expressed from a secondary plasmid in the same strain, and then purified via a StrepTrap column. In the second method, ex vivo capping, clarified lysates of the HT1T2T3 expressing strain and a separate strain expressing PSII were mixed and after a brief incubation, purified via StrepTrap. Excess PSII proteins and trace contaminants were subsequently removed via anion-exchange chromatography (see Methods for details and Supplementary Figs. 1–3 for complete purification schemes and tracking). Figure 1a shows that HT1T2T3PSII shells are obtained when either the in vivo (lane 2) or ex vivo (lane 3) capping/pull-down methods are employed according to SDS-PAGE analysis. We observe no morphological changes to our affinity-purified shells (Fig. 1b–d), indicating that the Strep-II-tag is well-tolerated. It is unclear why there are subtle differences in the abundance of contaminants between lanes 2 and 3 (e.g., the band migrating between 50 and 75 kDa), however these observations are reproducible and may arise from the different plasmid content of the strains used (a double-transformed strain vs. a mixture of two singly-transformed strains). Nevertheless, the classically prepared shells are ~70% pure whereas both CAP-purified shell preparations are >95% pure and the entire protocol from cell pellets to shells can be performed in a matter of hours. In addition, the final yield of shells for the different methods is similar, ranging from 0.40 to 0.55 mg purified shell per gram cell pellet. Control reactions using a pentamer variant without the Strep-II tag fail to appreciably recover shells during the ex vivo CAP protocol, indicating that the method is dependent on specific interactions with the affinity resin (Supplementary Fig. 3c).
Analysis of the initial ex vivo capping experiment suggested that at the 1:2 (v/v) mixing ratio of pentamer lysate to shell lysate used, the pentamers are present in stoichiometric excess (i.e., greater than 12 pentamer subunits per shell particle). This is evidenced by a substantial peak comprised primarily of pentamer protein which elutes prior to the capped shells during the anion-exchange chromatography run (Supplementary Fig. 3b). While we cannot be certain at this stage that every vertex is occupied when pentamers are in such excess, we nonetheless performed a pentamer titration to determine whether putative substoichiometric amounts of pentamer provide sufficient avidity to pull-down the (presumably) partially capped shells. Equal volumes of shell lysates were mixed with a range of pentamer lysate amounts (as low as 1:160 pentamer to shell volumetric mixing) and CAP-purified. The eluates were subjected to SDS-PAGE analysis, this time without anion-exchange polishing steps in order to preserve the relative ratios of all eluted proteins. As shown in Fig. 1e, decreasing pentamer to hexamer band intensities in tandem with decreased pentamer loading indicate that sub stoichiometric amounts of pentamer are still able to recover shells and overall impact on shell yield is modest above a certain pentamer loading threshold. We attribute the trace amounts of shells recovered in the no-pentamer control lane to incomplete elution of pentamers and/or shells from previous StrepTrap chromatography runs. Together, these results indicate that partially capped shells maintain sufficient avidity to be CAP-purified—a property that may be applied toward rapid purification of shells that can still be loaded with cargo ex vivo through the remaining pentamer vacancies and then fully capped.
Finally, we show that other shell systems are amenable to affinity-based purification by appending a Strep-II tag to the pentameric CcmL protein in a synthetic operon used to produce beta-carboxysomal shells from Halothece sp. PCC 741819 (Halo hereafter). As with the in vivo CAP described above, proteins were heterologously expressed in E. coli and purified by StrepTrap and anion-exchange. Figures 1f, g reveals that highly pure, morphologically homogeneous particles are obtained via affinity purification. In the native systems, the absence of CcmL typically results in elongated carboxysomes; the presence of pentamer seems to be required for the termination of facet growth10,25. Accordingly, uncapped synthetic carboxysome shells cannot be complemented in trans as in the ex vivo CAP method used for HO shells. Nevertheless, the rapid isolation of BMCs of a completely different type suggests the method may be broadly applicable to other shells systems.
CAP facilitates screening of shell formation to define a minimal shell
Recent work in our lab2 revealed HO shells to be T = 9 icosahedra with one of the three possible BMC-T (T1–3) proteins occupying the central position of each facet. Due to high shape complementarity between the trimers despite significant primary sequence divergence, we predicted that the trimers would be interchangeable. We therefore employed CAP to screen for the potential formation of shells comprised of the hexamer, one of the three trimers, and the pentamer protein. Shells were produced by expression from three plasmids each bicistronically expressing the hexamer and a single trimer. Because we were employing this method as a facile screen for shell assembly, we omitted subsequent anion-exchange polishing steps. Consequently, by ensuring PSII protein is in stoichiometric excess and equally applied to each HTn lysate, densitometric analysis of the PSII to hexamer band-intensity ratios gives a crude measure of relative shell yields (SDS-PAGE samples are loaded based on normalized A280 values).
As shown in Fig. 2a, expression of any single BMC-T domain with BMC-H is sufficient to form shells as assayed by CAP. To our knowledge, shell formation from just a single species each of hexamer, trimer and pentamer proteins has not previously been observed. Because identical trimers occupy each facet in these minimal shells, the method provides a means of isolation of BMC shells that are molecularly defined icosahedra. Interestingly, the PSII to BMC-H ratios reveal notable differences between the band intensities of the three shell preparations. Whereas shells comprised of just T1 and T3 trimers (HT1PSII and HT3PSII, respectively) show similar pentamer:hexamer ratios (lanes 1 and 3), the yield of HT2PSII shells is markedly reduced as indicated by a lower hexamer:pentamer band-intensity ratio. Whether this is attributable to the impact a particular BMC-T has on shell assembly efficiency or is merely an artifact of differential expression/stability between the trimers remains undetermined. We note no major morphological differences in these minimal shell preparations, further reinforcing the notion that each individual trimer serves identical structural roles within the context of the shell architecture, despite their presumed differences in permeability (Fig. 2b, d).
EnCO enables robust encapsulation of cargo
To date, published encapsulation methods for heterologous cargo have been inefficient19,20,21,22. We sought a synthetic route to encapsulation that circumvents the shortcomings of EPs by using the SpyTag/SpyCatcher split bacterial adhesin system26. This technology relies on genetically fusing a 9 kDa SpyCatcher domain to one protein partner and a 1.4 kDa (13 residue) SpyTag to another protein partner. When the SpyCatcher and SpyTag polypeptides encounter one another, an isopeptide bond autocatalytically forms between them, covalently linking the two partner proteins. We reasoned that a SpyCatcher or SpyTag localized to the lumen of a BMC shell would serve as a defined docking site for cargo protein tagged with SpyTag or SpyCatcher (respectively).
T1 was chosen as a target for insertional mutagenesis of the SpyTag and SpyCatcher sequences. As shown in Fig. 3a, a region was identified on the lumenal side between alpha-helix two and beta-strand four, which is not predicted to make any contacts with neighboring shell proteins and which lies ~24 Å from the subunit’s central pore (the entire subunit is ~70 Å edge-to-edge). This spacing from the threefold symmetry axis of the subunit mitigates the possibility of steric clashes from inserted/conjugated domains which could prevent the assembly of individual protomers into the trimeric subunit and/or result in incomplete cargo conjugation. SpyCatcher and SpyTag, flanked by six residue glycine-serine linkers, were inserted into T1 to create TSC and TST constructs, respectively (Fig. 3b, c).
The wild-type T1 was replaced with the TSC and TST mutants in plasmids that express the full complement of trimers (pHT1T2T3) as well as the minimal shell producing pHT1 plasmid to create, respectively, pHTSCT2T3/pHTSC and pHTSTT2T3/pHTST. SpyTag and SpyCatcher was appended to the N-terminus of the cyan fluorescent protein mTurquoise227 and cloned into a compatible and orthogonally inducible plasmid with a C-terminal hexahistidine tag (STcfp).
Shell and cargo plasmids were co-transformed and shell expression was induced either with or without simultaneous induction of STcfp cargo. CAP was then used to isolate the resultant shells. SDS-PAGE analysis of unpolished eluates is shown in Fig. 4a. In contrast to the wild-type shells in lane 1 in which the wild-type T1 protein is detected at its normal relative abundance, the TSC is undetectable in the putative HTSCT2T3PSII shells. However in lane 3, the fused TSC~STcfp trimer, which migrates at ~75 kDa, is observed—likely due to the increase in the protein mass upon conjugation to cargo allowing the fusion to exceed the stain’s limit of detection. This would suggest that the TSC protein is at a modest competitive disadvantage for integration into shells compared to wild-type T1 and T2/T3 and/or could result from reduced solubility of TSC relative to T1. Nevertheless, these HTSC~STcfpT2T3PSII shells exhibit normal morphology by microscopic analysis and have a fluorescence emission spectrum consistent with mTurquoise2 (Supplementary Figs. 4a, b), thus proving that cargo-fused TSC can integrate into shells without any gross morphological disruption. Furthermore, whereas EP-based encapsulation in the HO shell system (among others) requires western blotting to detect cargo, the detection of loaded cargo by coomassie stain alone represents a significant improvement over existing methods.
Minimal shells harboring only the TSC subunit have more cargo binding capacity due to the absence of competition for the trimer subunit position with T2 and T3 proteins—a theoretical 60 copies of cargo could be recruited by the twenty trimeric subunits. This was confirmed by characterizing cargo loading using the pHTSC plasmid and results are shown in Fig. 4a lanes 4–6. Lane 5, in which expression of cargo is not induced, now reveals the presence of TSC as expected (lest no shells be formed) and lane 6 shows the TSC band is nearly completely converted to the cargo-fused TSC~STcfp form in these shell preparations. Interestingly, a small amount of free STcfp co-purifies with the shells (lane 6) which could be a result of stochastic encapsulation or proteolytic deconjugation from TSC. Western blotting against the hexahistidine tag present in STcfp confirms the identity of these proteins and reveals that the faint band at ~75 kDa in lane 5 is a contaminant and not TSC~STcfp which could result from leaky expression of the STcfp in the absence of inducing agent (Supplementary Fig. 4c).
When SpyTag is inserted into T1 and SpyCatcher-fused to cargo (i.e. the inverse arrangement), similar behavior is observed in the context of full shells: the TST~SCcfp fusion is detected but not at the relative abundance expected in wild-type HT1T2T3PSII shells (Fig. 4b lane 1). However, in comparison to the minimal HTSC~STcfpPSII shells in Fig. 4a lane 6, a significant fraction of the TST subunit remains unconjugated to the SCcfp cargo (Fig. 4b lane 2). This could indicate that the TST is less efficient at recruiting cargo compared to TSC and/or that SpyCatcher-fused cargo is sterically frustrated from productive binding to the TST subunit. A final, non-mutually exclusive scenario is that shells form prior to cargo recruitment and the larger SCcfp (42.7 kDa) is less able to transit the pentamer vacancies compared to STcfp (29.9 kDa). HTST~SCcfpPSII shells are obtained at levels similar to HT1T2T3PSII shells (0.40 mg per gram of cell pellet) while HTSC~STcfpPSII shells incur a significant reduction in yield (0.04 mg per gram cell pellet), though purity is comparable after anion-exchange chromatography is performed (Supplementary Fig. 5a). Finally, we calculated the number of cfp cargo proteins per shell using fluorescence intensity values and find that HTSC~STcfpPSII shells have ~73 copies per shell and HTST~SCcfpPSII shells have ~58 copies per shell (Supplementary Fig. 5b). These numbers are in reasonable agreement with theoretical estimates based on percent conversion of the trimers to their respective conjugates as observed in SDS-PAGE analysis.
Based on the assembly principles and structure of HO shells reported by Sutter et al.2, the minimal shells in lanes 4–6 harbor 20 trimer subunits, nearly all of which are conjugated to cargo in the HTSC~STcfpPSII shell preparations according to the aforementioned SDS-PAGE and fluorescence analysis. This should increase the apparent shell thickness and indeed, examination of transmission electron micrographs of the minimal shell compositions depicted in Fig. 4a lane 6 reveal notable differences in shell appearance: cargo-loaded shells appear thicker at ~6.2 nm and more stippled compared to HT1PSII shells (Fig. 2b, ~4.7 nm; measurements are mean of n = 3 discrete shells) as well as empty HTSCPSII shells (Supplementary Fig. 6; see Supplementary Fig. 7 for shell measurements). Together, these findings validate EnCo as a robust method for encapsulation of cargo into morphologically undisrupted shells using trimer subunits functionalized with molecular traps.
Multiple cargo proteins can be loaded ex vivo at defined ratios
The in vivo encapsulation results do not allow us to distinguish between two non-mutually exclusive scenarios: TSC/ST~cargo conjugation occurs prior to integration into proto-shells, or empty shells form first and cargo then conjugates to the trimer subunits after entry through the pentamer holes. The pentamer vacancies are ~47 Å diameter and can accommodate mTurquoise2 (Supplementary Fig. 8a). We tested whether cargo could be loaded into pre-formed shells ex vivo in biological duplicates by mixing clarified lysates of strains expressing HTSC shells with clarified lysates containing the previously described STcfp as well as SpyTagged yellow fluorescent protein, SYFP228 (STyfp) at varying volumetric ratios. These two fluorophores are spectrally well-matched as a Förster resonance energy transfer (FRET) pair27 and therefore their co-localization is detectable spectrophotometrically. Expression under identical conditions in separate strains results in the same abundance of the STcfp and STyfp proteins in whole cell lysates (Supplementary Fig. 8b).
After cargo loading, the mixtures were subjected to CAP and analyzed spectrophotometrically; flow-through fractions which contain unencapsulated STcfp/STyfp were also collected for comparison. Shells were excited at 405 nm (a wavelength capable of STcfp excitation with negligible excitation of STyfp) and emission spectra were collected from 450 to 600 nm. As shown in Fig. 5a, increasing the proportion of STyfp in the mixture attenuates the emission of STcfp (emission maximum 474 nm) with a concomitant increase in emission from STyfp (emission maximum 527 nm) indicating FRET and co-localization of the two fluorophores. Comparison of the fluorescence intensities of the two fluorophores in both the shell preparations and flow-through fractions corroborate these emission scan data (Supplementary Fig. 8d). These data demonstrate that STcfp and STyfp co-localization is mediated by co-encapsulation within HTSC shells and that multi-cargo relative abundances can be easily programmed via ex vivo encapsulation—an important consideration for optimizing flux through multi-enzyme cascades and which is not readily achievable in vivo without laborious optimization of cargo expression levels. Finally, the encapsulation efficiency of ex vivo cargo loading for these HTSC~STcfpPSII shells was assessed by SDS-PAGE analysis along with the inverted architecture (HTST~SCcfpPSII shells). As shown in Fig. 5b, c, the amount of unconjugated TSC and TST is similar, if not lower compared to the in vivo encapsulation experiments (Fig. 4a lane 6 and 4b lane 2). Because these ex vivo-loaded shells are formed prior to the introduction of cargo, this indicates that the observed relative encapsulation efficiency of the two EnCo architectures is not due to the different sizes of cargo transiting through the pentamer gaps. Control experiments in which incompatibly-tagged cargo was tested for encapsulation (e.g., using SCcfp with HTSC shells) reveals non-specific stochastic encapsulation is minor (Supplementary Fig. 8e).
Interrogation of HO shell permeability using a FRET-based sensor
In comparison to storage-based nanocompartments like viruses and ferritins29, BMC function depends on selective permeability to an array of molecules—the identities of which depend on the particular native physiological function of a given BMC (recently reviewed in ref.30). The uncapped HO shells admit macromolecular species yet should prevent their entry/egress when fully capped. To test this behavior and confirm that CAP results in fully complemented shells, we developed a FRET-based permeability probe and apply it towards elucidating the permeability of HO shells to protein and small molecule size scales. The tobacco etch virus protease (TEVp) cleavage site31 followed by a six-residue tetracysteine motif was inserted between the C-terminus of mTurquoise2 and the hexahistidine tag of the STcfp construct to create the SpyTagged permeability probe, STprobe. Tetracysteine motifs tightly and specifically bind conditionally fluorescent biarsenical dyes such as the fluorescein-derived FlAsH reagent32. At 664.5 Da and ~10 Å at its narrowest point, the FlAsH reagent is in a similar size regime as cofactors like NADPH (744.4 Da) and therefore may be admitted through some subunit pores—likely one or more trimers, as the hexamer’s ~6.8 Å pore is too small to accommodate the FlAsH reagent5,33,34. The spectral properties of FlAsH are similar to SYFP2; binding to STprobe positions the fluorophore within the Förster distance of mTurquoise2 and therefore this event can be detected spectrophotometrically. The spectral shift can subsequently be reversed by proteolytic removal of the labeled tetracysteine motif using TEVp. STprobe’s design and spectrophotometric behavior in response to incubation with FlAsH and TEVp when unencapsulated are depicted in Fig. 6a, b. Because TEVp also removes the C-terminal hexahistidine tag from the probe, cleavage can also be detected using western blotting against this epitope. SDS-PAGE analysis of the final probe preparation and western blotting confirm that, as expected, the BMC-P protein itself has no inhibitory activity on TEVp (Supplementary Fig. 9a, b).
We performed a classical shell preparation of STprobe-loaded, uncapped shells (HTSC~STprobeT2T3). Addition of the FlAsH reagent to the shells results in a fluorescence emission shift which is reverted upon TEVp addition (Fig. 6c, top row), recapitulating the behavior of unencapsulated probe. This demonstrates, as expected, that FlAsH and TEVp (~36 Å in diameter) can enter the shells and proteolyze the encapsulated probe. We next show that shells pre-capped via incubation with purified pentamer (HTSC~STprobeT2T3PSII) still undergo a spectral shift when FlAsH is added, yet show no reversion in spectral emission upon addition of TEVp (Fig. 6c, bottom row). Exclusion of TEVp from these capped shells is confirmed by western blot analysis (Supplementary Fig. 9d). We conclude that addition of the pentamer to uncapped shells is necessary and sufficient to preclude the entry of TEVp, though interestingly, these capped shells remain permeable to the FlAsH reagent, indicating it may be entering through the pores of one or more subunits. By leveraging EnCo for encapsulation of a permeability probe, these data indicate that CAP yields fully complemented shells with no unoccupied pentamer positions.
In this study, we have elaborated the function of bacterial microcompartment shell proteins through the introduction of affinity handles and molecular traps. Complementation-based affinity purification (CAP) enables rapid purification of shells and by extension, screening for the formation of particles comprising varying subunits. Encapsulation via covalent-linkage (EnCo) allows facile programming of cargo composition expressed in cis and in trans. Using a permeability probe, we unambiguously demonstrate that shells capped in trans are fully complemented barriers against the transit of a macromolecular species (TEV protease) and yet admit the small molecule, FlAsH—likely through one or more of the distinct types of pores found in the shell proteins.
Previous work has shown that other BMCs such as the carboxysome can form without pentamers, though aberrant structures were observed microscopically in cells6,10,25. In contrast, we observe no structural polymorphisms in HO shell preparations when pentamers are absent. Moreover, the isolation of morphologically undisrupted minimal shells, each harboring a single trimer species, implies redundancy at the structural level while differing pore and stacking configurations implicate non-redundant functions in selective molecular transport across the shell. The ability to form uncapped shells enables the encapsulation of cargo ex vivo. As demonstrated, this allows multiple cargo species (which need not be expressed in the shell host) to be introduced into the shells at programmed ratios. Trapping SpyTag/SpyCatcher-fused cargo in shells via EnCo is simple and efficient; however in principle any species able to transit the 47 Å diameter pentamer gap could be captured via co-incubation and capping. Such stochastic encapsulation would be of particular use in encapsulating molecules which cannot be tagged (e.g., acyl-CoA substrates), or even wholly abiotic materials.
Although there is a report of affinity enrichment of bacterial microcompartments35, the resultant particles were heterogeneous and morphologically aberrant. This may be attributable to appending hexahistidine tags to multiple shell proteins which may sterically frustrate proper assembly. In contrast, the lack of any pentamer-pentamer subunit interactions in assembled shells advantages the use of this building block for embelishments and we have demonstrated that very few Strep-II tags per particle provide sufficient avidity to pull-down highly pure shells. The isolation of beta-carboxysomal (Halo) shells demonstrates that this affinity pull-down strategy is applicable to other microcompartments that frequently exhibit morphological heterogeneity. Given the homology among the shell proteins of all BMCs, we expect that this method, after identifying specific combinations of subunits to form synthetic shells, will be generally applicable to other BMC systems.
The observations by us and others that encapsulation peptides are often ineffective at recruiting heterologous cargo to the lumen of BMC shells motivated us to pursue alternative means of encapsulation. Strategies for nanoparticle encapsulation such as engineering complementary electrostatics have proven useful for other nanocontainers such as lumazine synthase36. However, this approach is not targeted and may non-specifically package resident charged molecules (e.g., nucleic acids) when performed in vivo. The SpyTag/SpyCatcher system has been used for encapsulation in other nanocompartments such as MS2 viral capsids and excitingly, encapsulated enzymes were shown to be more robust37. However MS2 viral capsids are composed of a single protein type and therefore lack any potential for compositional plasticity which may decrease their utility. We believe that shared architectural features and structurally homologous insertion sites will allow translation of the SpyCatcher/SpyTag system to other BMC types. Moreover, despite the demonstrated superiority of EnCo to existing technology, improvements may be realized with additional protein engineering. For example alternatives to the currently employed poly-G/S linkers that flank SpyTag/SpyCatcher could improve solubility, cargo recruitment and integration into shells. Additionally, because expression and shell formation dynamics remain unexplored, in vivo metabolic engineering applications will require empirical testing of induction timing and strength to optimize loading efficiency.
While numerous studies have demonstrated that the permeability of BMCs can be altered via rational mutagenesis of pore-lining residues, or even whole-sale swapping of subunits from one BMC system to another38,39,40, assessing BMC permeability to a given small molecule is non-trivial, much less elucidating the permeability of specific subunits to said molecule. Our fluorescence-based probe serves as proof-of-principle for the use of these shell protein functionalizations for assessing shell permeability to small molecules in real time. In principle, any encapsulated enzymatic transformation(s) that results in a spectroscopic signal could serve as a readout of shell permeability, enabling the characterization of shell permeability to physiologically relevant species such as NAD(P)H. Leveraging the plasticity of subunit composition combined with altered selectivity from pore mutagenesis could allow for the facile creation of shells with bespoke permeabilities—likely a vital step toward increasing efficiencies of encapsulated, non-native pathways. The development of the EnCo and CAP methods represent significant steps towards more accessible physiological studies as well as realizing the biotechnological promises of bacterial microcompartments.
BL21(DE3) strains harboring shell plasmids were grown to OD600 0.6–0.8 in lysogeny broth at 37 °C with 100 µg/mL ampicillin and induced with 50 µM IPTG with a brief cold-shock on ice. When co-expressing SpyTag/SpyCatcher cargo or PSII, strains were additionally cultured with 50 µg/mL kanamycin and induced simultaneously with 5 ng/mL anhydrotetracycline. Incubation was then continued at 18 °C for 16–20 h.
Classical shell purifications
Shells were prepared using methods described in ref. 2. Briefly, the cell pellet from a 2 L culture expressing pHT1T2T3 was resuspended in Tris-buffered saline (20 mM Tris, 50 mM NaCl, pH 7.4 TBS 20/50 hereafter), lysed by French press and clarified by centrifugation at 25,000×g for 30 min. After sucrose cushion and sucrose gradient centrifugations, shells were further purified by application to a MonoQ 10/100 GL anion-exchange column connected to an Äkta Pure system and elution with a shallow sodium chloride gradient (200–400 mM NaCl over 10 column volumes). Shell containing fractions were pooled and concentrated with a 15 mL 100 kDa MWCO filter (Amicon) and stored on ice after the addition of 0.02% sodium azide as a preservative. For HTSC~STprobeT2T3 shells, classically purified HTSCT2T3 shells were incubated overnight with an excess of purified STprobe (see Supplementary Methods/Expression and purification of STprobe protein) at 4 °C and then excess STprobe was removed via application to a HisTrap column, followed by another MonoQ step. All buffers for the HTSC~STprobeT2T3 shell preparation were amended with 5 mM EDTA and 5 mM TCEP to maintain reducing conditions.
Complementation-based affinity purification
For initial in vivo and ex vivo capping, cell pellets from 1 L pHT1T2T3 cultures were lysed using BPER-II amended with recombinant lysozyme and benzonase according to manufacturer’s recommendation and clarified by centrifugation as above. Shell lysates were then mixed with clarified PSII lysates (2:1 v/v ratio of shell to pentamer pellets for HT1T2T3 shells; 10:1 for all minimal shells; see Supplementary Methods/Expression and purification of PSII protein) and incubated for 30 min to allow capping to occur. Lysates were then applied to a 5 mL StrepTrap (GE Healthcare) column equilibrated with Buffer A (100 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA). The column was washed with six column volumes Buffer A and proteins were eluted in six column volumes Buffer B (20 mM Tris-HCl, pH 7.4, 50 mM NaCl, 1 mM EDTA, 2.5 mM D-desthiobiotin). Where specified, shells were further purified with anion-exchange chromatography and/or concentrated with 100 kDa molecular weight cut-off Amicon spin filters as described. Capping experiments involving encapsulated cargo (Figs. 4, 5) were scaled down to 0.2 L shell cultures and purified with 1 mL StrepTrap columns using otherwise identical methods.
Ex vivo capping was performed as described above except a range of clarified PSII lysate amounts (25, 10, 2.5, 1.25, and 0 mL equivalents) was added to 0.2 L equivalents pHT1T2T3 shell lysate.
Ex vivo loading of cargo into minimal shells
Cultures of pET11n::HTSC/ST, pBbA2k::ST/SCmTurquoise2-6xHis and pBbA2k::STSYFP2-6xHis were induced with 50 µM IPTG (pET11n::HTSC/ST) or 50 ng/mL aTc (pBbA2k::ST/SCmTurquoise2-6xHis, pBbA2k::STSYFP2-6xHis). Biological replicates (total n = 2) were performed with freshly re-transformed strains. Cell pellets were resuspended in Buffer A (4 mL per gram cell paste) supplemented with 12 µl benzonase (25 U/µl), a pinch of hen egg lysozyme and one Roche Complete EDTA-free protease inhibitor tablet, lysed using a French press and clarified by centrifugation as described. For co-encapsulation experiments, 0.2 L equivalents of the HTSC expressing lysate was mixed with a total of 0.2 L equivalent STcfp/STyfp lysates at varying ratios where one part corresponds to 20 mL equivalents lysate. For encapsulation of a single species (control reactions and loading into HTST shells), 0.2 L equiv. of shell lysate was mixed with 0.2 L equiv. cargo. Mixtures were incubated at room temperature overnight and then incubated with clarified PSII lysate and purified via 1 mL StrepTrap columns as described and concentrated with 0.5 mL 100 kDa MWCO spin filters to obtain sufficient fluorescent signal. For fluorescence comparisons to encapsulated STcfp/STyfp, the flow-through during sample application to the StrepTrap columns was collected.
Permeability experiments with FlAsH-EDT2 and TEVp
HTSC~STprobeT2T3 preparations (final protein concentration of ~1 mg/mL) or unencapsulated STprobe (~100 µg/mL) in 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 5 mM TCEP, 1 mM β-mercaptoethanol were incubated in the absence or presence of excess PSII in microtiter plates for sixty minutes. A FlAsH-EDT2 and 2,3-dimercapto-1-propanol solution (1 mM and 9 mM, respectively, in DMSO) was added such that the final FlAsH-EDT2 concentration was 10 µM and incubated at room temperature for 2 h. TEV protease was then added to a final concentration of 40 µg/mL (~1:20 w/w) and incubated for 2 h.
Refer to Supplementary Methods for additional notes on the following topics: chemicals and reagents; SDS-PAGE and western blot analysis of protein preparations; fluorescence intensity, spectra readings, and fluorescence normalization; electron microscopy. Plasmid construction is summarized in Supplementary Table 1. Full-frame TEM micrographs were provided in Supplementary Fig. 10.
Data supporting the findings of this study are available from the corresponding author upon reasonable request.
Axen, S. D., Erbilgin, O. & Kerfeld, C. A. A taxonomy of bacterial microcompartment loci constructed by a novel scoring method. PLoS Comput. Biol. 10, e1003898 (2014).
Sutter, M., Greber, B., Aussignargues, C. & Kerfeld, C. A. Assembly principles and structure of a 6.5-MDa bacterial microcompartment shell. Science 356, 1293–1297 (2017).
Tanaka, S. et al. Atomic-level models of the bacterial carboxysome shell. Science 319, 1083–1086 (2008).
Kerfeld, C. A. et al. Protein structures forming the shell of primitive bacterial organelles. Science 309, 936–938 (2005).
Klein, M. G. et al. Identification and structural analysis of a novel carboxysome shell protein with implications for metabolite transport. J. Mol. Biol. 392, 319–333 (2009).
Cai, F. et al. The pentameric vertex proteins are necessary for the icosahedral carboxysome shell to function as a CO2 leakage barrier. PLoS ONE 4, e7521 (2009).
Aussignargues, C., Paasch, B. C., Gonzalez-Esquer, R., Erbilgin, O. & Kerfeld, C. A. Bacterial microcompartment assembly: the key role of encapsulation peptides. Commun. Integr. Biol. 8, e1039755 (2015).
Fan, C. et al. Short N-terminal sequences package proteins into bacterial microcompartments. Proc. Natl Acad. Sci. USA 107, 7509–7514 (2010).
Kinney, J. N., Salmeen, A., Cai, F. & Kerfeld, C. A. Elucidating essential role of conserved carboxysomal protein CcmN reveals common feature of bacterial microcompartment assembly. J. Biol. Chem. 287, 17729–17736 (2012).
Cameron, J. C., Wilson, S. C., Bernstein, S. L. & Kerfeld, C. A. Biogenesis of a bacterial organelle: the carboxysome assembly pathway. Cell 155, 1131–1140 (2013).
Abdul-Rahman, F., Petit, E. & Blanchard, J. L. The distribution of polyhedral bacterial microcompartments suggests frequent horizontal transfer and operon reassembly. J. Phylogen. Evolution. Biol. 1 118 (2013).
Lawrence, J. G. & Roth, J. R. Evolution of coenzyme B12 synthesis among enteric bacteria: evidence for loss and reacquisition of a multigene complex. Genetics 142, 11–24 (1996).
Parsons, J. B. et al. Biochemical and structural insights into bacterial organelle form and biogenesis. J. Biol. Chem. 283, 14366–14375 (2008).
Conrado, R. J., Mansell, T. J., Varner, J. D. & DeLisa, M. P. Stochastic reaction-diffusion simulation of enzyme compartmentalization reveals improved catalytic efficiency for a synthetic metabolic pathway. Metab. Eng. 9, 355–363 (2007).
Jakobson, C. M., Tullman-Ercek, D., Slininger, M. F., & Mangan, N. M. A systems-level model reveals that 1,2-Propanediol utilization microcompartments enhance pathway flux through intermediate sequestration. PLoS Comput. Biol. 13, e1005525 (2017).
Sampson, E. M. & Bobik, T. A. Microcompartments for B12-dependent 1,2-propanediol degradation provide protection from DNA and cellular damage by a reactive metabolic intermediate. J. Bacteriol. 190, 2966–2971 (2008).
Kim, E. Y. & Tullman-Ercek, D. Engineering nanoscale protein compartments for synthetic organelles. Curr. Opin. Biotechnol. 24, 627–632 (2013).
Plegaria, J. S. & Kerfeld, C. A. Engineering nanoreactors using bacterial microcompartment architectures. Curr. Opin. Biotechnol. 51, 1–7 (2018).
Cai, F., Bernstein, S. L., Wilson, S. C. & Kerfeld, C. A. Production and characterization of synthetic carboxysome shells with incorporated luminal proteins. Plant Physiol. 170, 1868–1877 (2016).
Lassila, J. K., Bernstein, S. L., Kinney, J. N., Axen, S. D. & Kerfeld, C. A. Assembly of robust bacterial microcompartment shells using building blocks from an organelle of unknown function. J. Mol. Biol. 426, 2217–2228 (2014).
Choudhary, S., Quin, M. B., Sanders, M. A., Johnson, E. T. & Schmidt-Dannert, C. Engineered protein nano-compartments for targeted enzyme localization. PLoS ONE 7, e33342 (2012).
Jakobson, C. M., Slininger Lee, M. F. & Tullman-Ercek, D. De novo design of signal sequences to localize cargo to the 1,2-propanediol utilization microcompartment. Protein Sci. 26, 1086–1092 (2017).
Erbilgin, O., Sutter, M. & Kerfeld, C. A. The structural basis of coenzyme a recycling in a bacterial organelle. PLoS Biol. 14, e1002399 (2016).
Schmidt, T. G. M., Koepke, J., Frank, R. & Skerra, A. Molecular interaction between the Strep-tag affinity peptide and its cognate target, streptavidin. J. Mol. Biol. 255, 753–766 (1996).
Price, G. D. & Badger, M. R. Isolation and characterization of high CO(2)-requiring-mutants of the Cyanobacterium Synechococcus PCC7942: two phenotypes that accumulate inorganic carbon but are apparently unable to generate CO(2) within the Carboxysome. Plant Physiol. 91, 514–525 (1989).
Zakeri, B. et al. Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin. Proc. Natl Acad. Sci. USA 109, E690–E697 (2012).
Goedhart, J. et al. Structure-guided evolution of cyan fluorescent proteins towards a quantum yield of 93%. Nat. Commun. 3, 751 (2012).
Kremers, G. J., Goedhart, J., van Munster, E. B. & Gadella, T. W. Jr. Cyan and yellow super fluorescent proteins with improved brightness, protein folding, and FRET Forster radius. Biochemistry 45, 6570–6580 (2006).
Arosio, P., Elia, L. & Poli, M. Ferritin, cellular iron storage and regulation. IUBMB Life 69, 414–422 (2017).
Kerfeld, C. A., Aussignargues, C., Zarzycki, J., Cai, F. & Sutter, M. Bacterial microcompartments. Nat. Rev. Microbiol. 16, 277–290 (2018).
Dougherty, W. G., Cary, S. M. & Parks, T. D. Molecular genetic analysis of a plant virus polyprotein cleavage site: a model. Virology 171, 356–364 (1989).
Griffin, B. A., Adams, S. R. & Tsien, R. Y. Specific covalent labeling of recombinant protein molecules inside live cells. Science 281, 269–272 (1998).
Cai, F. et al. The structure of CcmP, a tandem bacterial microcompartment domain protein from the beta-carboxysome, forms a subcompartment within a microcompartment. J. Biol. Chem. 288, 16055–16063 (2013).
Larsson, A. M., Hasse, D., Valegard, K. & Andersson, I. Crystal structures of beta-carboxysome shell protein CcmP: ligand binding correlates with the closed or open central pore. J. Exp. Bot. 68, 3857–3867 (2017).
Sargent, F. et al. A synthetic system for expression of components of a bacterial microcompartment. Microbiology 159, 2427–2436 (2013).
Seebeck, F. P., Woycechowsky, K. J., Zhuang, W., Rabe, J. P. & Hilvert, D. A simple tagging system for protein encapsulation. J. Am. Chem. Soc. 128, 4516–4517 (2006).
Giessen, T. W. & Silver, P. A. A catalytic nanoreactor based on in vivo encapsulation of multiple enzymes in an engineered protein nanocompartment. Chembiochem 17, 1931–1935 (2016).
Cai, F., Sutter, M., Bernstein, S. L., Kinney, J. N. & Kerfeld, C. A. Engineering bacterial microcompartment shells: chimeric shell proteins and chimeric carboxysome shells. ACS Synth. Biol. 4, 444–453 (2015).
Menon, B. B., Heinhorst, S., Shively, J. M. & Cannon, G. C. The carboxysome shell is permeable to protons. J. Bacteriol. 192, 5881–5886 (2010).
Slininger Lee, M. F., Jakobson, C. M. & Tullman-Ercek, D. Evidence for improved encapsulated pathway behavior in a bacterial microcompartment through shell protein engineering. ACS Synthetic Biol. 68, 3857–3867 (2017).
We thank Behzad Rad and Francesca Manea for plasmids and fruitful discussion of SpyTag/SpyCatcher technology, the labs of Adam Deutschbauer and Krishna Niyogi for instrument use and Denna Kwang for assistance with cloning. This work was supported by the National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) grant 1R01AI114975-01 with infrastructure support from the US Department of Energy, Basic Energy Sciences, Contract DE-FG02-91ER20021.
The authors declare no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
About this article
Cite this article
Hagen, A., Sutter, M., Sloan, N. et al. Programmed loading and rapid purification of engineered bacterial microcompartment shells. Nat Commun 9, 2881 (2018). https://doi.org/10.1038/s41467-018-05162-z
Probe into a multi-protein prokaryotic organelle using thermal scanning assay reveals distinct properties of the core and the shell
Biochimica et Biophysica Acta (BBA) - General Subjects (2020)
A Bioorthogonal Click Chemistry Toolbox for Targeted Synthesis of Branched and Well‐Defined Protein–Protein Conjugates
Angewandte Chemie International Edition (2020)
Covalent Functionalization of Bioengineered Polyhydroxyalkanoate Spheres Directed by Specific Protein-Protein Interactions
Frontiers in Bioengineering and Biotechnology (2020)
Current Opinion in Biotechnology (2020)
Redox Characterization of Electrode-Immobilized Bacterial Microcompartment Shell Proteins Engineered To Bind Metal Centers
ACS Applied Bio Materials (2020)